HOME   |   Contact Us   |   Sign In   |   Join Now
Virtual MSL Training - HEOR for MSLs: Enhancing Scientific Engagement and Impactful KOL Discussions
Register Tell a Friend About This EventTell a Friend
 

 Export to Your Calendar 12/5/2025
When: Friday, December 5, 2025
12:00 PM - 4:00 PM EST
Where: Virtual - Zoom
United States
Presenter: Samuel Dyer, MD, PhD, CEO, MSL Society, Mahesh K. Tawney, PharmD, MBA, Sr. Director, Alnylam
Contact: Heliana Sula
heliana.sula@themsls.org


Online registration is available until: 12/5/2025
« Go to Upcoming Event List  

HEOR for MSLs: Enhancing Scientific Engagement and Impactful KOL Discussions

 

Why This Program is Important

 

In the ever-evolving healthcare landscape, scientific exchange between MSLs and KOLs must extend beyond clinical trial data to include economic and real-world outcomes. Health Economics and Outcomes Research (HEOR) is a key driver in drug reimbursement, formulary access, and treatment adoption, making it essential for MSLs to understand its principles and applications.

 

While MSLs may not be directly responsible for conducting HEOR research, being able to confidently discuss HEOR data and translate its implications into meaningful insights for KOLs strengthens credibility and enhances engagement. This program equips MSLs with the knowledge, communication techniques, and strategic insights needed to integrate  HEOR into impactful KOL discussions.

 


 

Who This Program is For

 

This training is designed for MSLs at all levels who aim to strengthen their scientific engagement by integrating HEOR into discussions with KOLs, payers, and healthcare stakeholders.

 

New MSLs:

 

Those new to the MSL profession with limited exposure to HEOR.
MSLs looking to develop confidence in HEOR discussions with KOLs.

 

Experienced MSLs:

 

MSLs seeking to refine their ability to interpret and communicate HEOR data.
MSLs engaging with KOLs who serve as payer advisors or formulary committee members.

 

MSL Leaders & Managers:

 

Senior MSLs responsible for mentoring teams on HEOR communication.
MSL managers looking to integrate HEOR knowledge into medical affairs strategies.


Learning Outcomes

 

By the end of this training, participants will be able to:

  1. Understand the fundamentals of HEOR and its role in drug evaluation and healthcare decision-making.
  2. Recognize when and how HEOR discussions arise in MSL-KOL interactions.
  3. Interpret and effectively communicate HEOR metrics such as ICERs, QALYs, and budget impact analyses.
  4. Differentiate between Real-World Data (RWD) and Real-World Evidence (RWE) and explain their implications.
  5. Apply HEOR insights to enhance KOL engagement and strengthen the scientific exchange.
  6. Handle HEOR-related questions from KOLs in a compliant and impactful manner.
  7. Strategically integrate HEOR into broader medical affairs initiatives to increase engagement value.
  8. Collaborate cross-functionally with internal HEOR, market access, and medical teams to drive scientific alignment.

Training Topics

 

1. HEOR Fundamentals for MSLs

 

📌 Core principles and why HEOR matters for scientific and economic decision-making.
📌 How HEOR complements clinical trial data and supports value demonstration.

 

2. HEOR’s Role in KOL Engagement & Market Access

 

📌 Why KOLs care about HEOR and how it influences drug reimbursement and access.
📌 How MSLs can engage KOLs in HEOR discussions to enhance scientific credibility.

 

3. Interpreting HEOR Data & Metrics

 

📌 Understanding key HEOR methodologies:
Cost-effectiveness analysis (CEA), ICERs, QALYs, and budget impact analysis.
📌 Translating HEOR findings into clinically relevant insights for KOL discussions.

 

4. Generating and Utilizing HEOR Data

 

📌 Common HEOR data sources:
RWD, patient-reported outcomes, and registries.
📌 How HEOR studies are designed and analyzed to inform decision-making.

 

5. Communicating HEOR Effectively to KOLs

 

📌 Best practices for simplifying complex HEOR data while maintaining accuracy.
📌 Addressing common misconceptions and concerns KOLs have about HEOR.

 

6. HEOR in Practice: Real-World Scenarios for MSLs

 

📌 Case studies on how HEOR has impacted payer decisions and treatment adoption.
📌 Role-playing exercises to practice HEOR discussions in real-world KOL interactions.

 

7. Regulatory & Ethical Considerations in HEOR Discussions

 

📌 What MSLs can and cannot say about HEOR from a compliance perspective.
📌 Best practices for ensuring regulatory adherence in HEOR discussions.

 

8. Strategic Utilization of HEOR in Medical Affairs

 

📌 How HEOR supports long-term strategic scientific engagement.
📌 Cross-functional collaboration with market access, HEOR, and commercial teams.


Scenario-Based Activities

 

Throughout the training, participants will engage in interactive exercises designed to improve HEOR communication skills:

 

Matching HEOR Terms & Definitions: Strengthen HEOR knowledge by defining and applying key terms (ICERs, QALYs, BIA).
RWD vs. RWE Role-Playing: Practice explaining the difference between RWD and RWE to a KOL serving on a payer advisory board.
KOL Engagement Simulations: Multiple role-play conversations where an MSL addresses HEOR-related questions from a KOL.

 


Registration Fees

Established Countries

  • $500.00 USD (Non-Members and Guest Members)

  • $450.00 USD (Professional and Organizational Level Members)

Emerging Countries (Requires a promo code provided upon request) 

  • $380.00 USD (Non-Members and Guest Members)

  • $300.00 USD (Professional Level Members and Organizational Level Members)

The Established and Emerging Country pricing tiers are based on the UN's Humanitarian Development Index (HDI), which does not use economic growth as the sole criteria of a country's capacity, but also assesses the capabilities of its citizens. The HDI is based on 3 indices, namely the Life Expectancy Index, the Education Index, and the GNI (Gross National Income) Index. You can learn more about it here

Established Countries include the following: Australia, Austria, Belgium, Canada, Cyprus, Denmark, Finland, France, Germany, Hong Kong, China (SAR), Iceland, Ireland, Israel, Italy, Japan, Korea (Republic of), Liechtenstein, Luxembourg, Malta, Netherlands, New Zealand, Norway, Singapore, Slovenia, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom and the United States.

*Emerging Countries include all other countries not mentioned in the list above.

* PLEASE NOTE-The "Emerging Countries" level is NOT available for those living or working in an "Established Country". All enrollments will be verified.

Please send an inquiry to Cedric de la Seña at cedric.delasena@themsls.org to take advantage of the special pricing if you are currently in one of the Emerging Countries mentioned above.

Don't miss out on this incredible learning and networking opportunity in our virtual training—limited seats available, enroll today!


Additional Information:

Cancellation Policies


Training Event Schedules
MSL Training schedules are subject to change without notice based on minimum attendance requirements. Please check session’s schedules frequently. The MSL Society may cancel scheduled classes up to ten (10) days prior to the scheduled start of the event if certain attendance minimums aren't met.

Refund Policy
A cancellation of a scheduled virtual training date made before Ten (10) days prior to the scheduled session will be refunded 100% of the registration fee. After this deadline, we will not be able to offer any refunds. However, if you are unable to attend the program, we can transfer your registration to a future session and guarantee your seat.

Proprietary Interest Policy
MSLS requires that any person that works with MSLS to develop or conduct training in any capacity must divulge their interests in any products, instruments, devices, or materials included in their training. MSLS has no financial interest or related personal interest or bias in any business whose products or services 

Membership Management Software  ::  Legal